Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization

Diagnostic Molecular Pathology

Volumn 8, Issue 1, 1999, Pages 47-53

  Wilkens, Ludwig ^a   Burkhardt, Dagmar ^a   Tchinda, Joelle ^a   Büsche, Guntram ^a   Werner, Martin ^b   Nolte, Martina ^a   Ganser, Arnold ^a   Georgii, Axel ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Comparative genomic hybridization; Cytogenetics; Fluorescence in situ hybridization; Histopathology; Myelodysplastic syndrome

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CHROMOSOME 5; CHROMOSOME 7; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FLUORESCENCE MICROSCOPY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; INTERMETHOD COMPARISON; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE MARROW CELLS; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 5; DNA; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKOCYTES; MALE; METAPHASE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NUCLEIC ACID HYBRIDIZATION;

EID: 0033067311     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199903000-00008     Document Type: Article

References (47)

1. Asimakopoulos FA, White NJ, White J, Nacheva E, Green AR. Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood 1994;84:3086-94.
2. Bartram. Molecular genetic aspects of myelodysplastic syndromes. Semin Hematol 1996;33:139-49.
3. Bartl R, Frisch B, Baumgart R. Morphologic classification of the myelodysplastic syndrome (MDS): combined utilization of bone marrow aspirates and trephine biopsies. Leuk Res 1992;16:15-33.
4. Benett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51:189-99.
5. Benett JM. Classification of the myelodysplastic syndromes. Clin Haematol 1986;15:909-23.
6. Bentz M, Huck K, du Manoir S, et al. Comparative genomic hybridisation in chronic B-cell leukemias shows a high incidence of chromosomal gains and losses. Blood 1995a;85:3610-8.
7. Bentz M, Dohner H, Werner-CA, et al. Identification of genetic imbalances in malignant lymphoma using comparative genomic hybridization. Stem Cells 1995b;13:83-7.
8. Bernhards J, Weitzel B, Werner M, Rimpler M, Georgii A. A new histological embedding method by low-temperature polymerisation of methyl methacrylate allowing immuno-and enzyme histochemical studies on semi-thin sections of undecalcified bone marrow biopsies. Histochem 1992;98:145-54.
9. Dewald GW, Schad CR, Lilla VC, Jalal SM. Frequency and photographs of HGM 11 chromosome anomalies in bone marrow samples from 3,996 patients with malignant hematologic neoplasms. Cancer Genet Cytogenet 1993;68:60-9.
10. Döhner H, Pohl S, Bulgay-Mörschel M, Stilgenbauer S, Bentz M, Lichter P. Trisomy 12 in chronic lymphoid leukemias-A metaphase and interphase cytogenetic analysis. Leukemia 1993;7: 516-20.
11. du Manoir S, Speicher MR, Joos S, et al. Detection of complete and partial chromosome gains and losses by comparative genomic hybridization. Hum Genet 1993;90:590-610.
12. Feneaux P, Morel P, Rose C, et al. Prognostic factors in adult de novo myelodysplastic syndromes treated by intensive chemotherapy. Br J Haematol 1991;77:497-501.
13. Feneaux P, Morel P, Laì JL. Cytogenetics of myelodysplastic syndromes. Semin Hematol 1996;33:127-38.
14. Fialkow PJ, Jacobson RJ, Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am J Med 1977; 63:125-30.
15. Gosden CM, Davidson C, Robertson M. Lymphocyte culture in human cytogenetics. In: Rooney DE, Czepulkowski BH, eds. Human cytogenetics: a practical approach. Oxford: Oxford University Press, 1992:31-54.
16. Grigg AP, Gascoyne RD, Philips GL, et al. Clinical haematological and cytogenetic features in 24 patients with structural rearrangements of the Q arm of chromosome 3. Br J Haematol 1993;83: 158-65.
17. Heerema NA, Argyropoulos G, Weetman R, Tricot G, Secker-Walker LM. Interphase in situ hybridization reveals minimal residual disease in early remission and return of the diagnostic clone in karyotypically normal relapse of acute lymphoblastic leukemia. Leukemia 1993;7:537-43.
18. Heim S. Cytogenetic findings in primary and secondary MDS. Leuk Res 1992;16:43-6.
19. Isola JI, Kallioniemi OP, Chu LW, et al. Genetic aberrations detected by comparative genomic hybridisation predict outcome in node negative breast cancer. Am J Pathol 1995;147:905-11.
20. Jenkins RB, LeBeau MM, Kraker WJ, et al. Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 1992;79:3307-15.
21. Kallioniemi A, Kallioniemi OP, Sudar D, et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 1992;258:818-21.
22. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridisation: A rapid new method for detecting and mapping DNA amplification in tumours. Semin Cancer Biol 1993;4:41-6.
23. Kibbelaar RE, Mulder JWR, Dreef EJ, et al. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridisation. Blood 1993;82:904-13.
24. Knuutila S, Bjørkqvist A, Autio K, et al. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridisation. Am J Pathol 1998;152:1107-23.
25. Kouides PA, Bennett JM, Morphology and classification of the myelodysplastic Syndromes and their pathologic variants. Semin Hematol 1996;33:95-110.
26. Mangi MH, Mufti GJ. Primary myelodysplastic syndromes: Diagnostic and prognostic significance of immunohistochemical assessment of bone marrow biopsies. Blood 1992;79:198-205.
27. Maschek H, Kaloutsi V, Werner M, et al. Myelosclerosis in primary myelodysplastic syndromes. Eur J Haematol 1992;48: 208-14.
28. Maschek H, Gutzmer R, Choritz H, Georgii A. Life expectancy in primary myelodysplastic syndromes: A prognostic score based upon histopathology from bone marrow biopsies of 569 patients. Eur J Haematol 1994;53:280-7.
29. Mecucci C, van den Berghe H. Cytogenetics. Hematol Oncol Clin North Am 1992;6:523-41.
30. Mitelman F. An international system for human cytogenetic nomenclature. Farmington, CT: Karger Publishers 1995.
31. Morel P, Hebbar M, Lai JL, et al. Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report of 408 cases. Leukemia 1993;7:1315-23.
32. Nolte M, Werner M, Ewig M, et al. Fluorescence in situ hybridization (FISH) is a reliable diagnostic tool for the detection of the 9;22 translocation. Leuk Lymph 1996;22:287-94.
33. Nowell PC. Chromosome abnormalities in myelodysplasticsyndromes. Semin Oncol 1992;19:25-33.
34. Ohyashiki JH, Ohyashiki K, Shimamato T, et al. Ecotropic virus integration site-1 gene preferentially expressed in post-myelodysplasia acute myeloid leukemia: Possible association with GATA-1, GATA-2 and stem cell leukemia gene expression. Blood 1995;85: 3713-8.
35. Parente F, Gaudray P, Carle GF, Turc CC. Experimental assessment of the detection limit of genomic amplification by comparative genomic hybridization CGH. Cytogenet Cell Genet 1997;78: 65-8.
36. Petersen I, Langreck H, Wolf G, et al. Small-cell lung cancer is characterized by a high incidence of deletions in chromosomes 3p, 4q, 5q, 10q, 13q and 17p. Br J Cancer 1997;75:79-86.
37. Pinkel D, Straume T, Gray JW. Cytogenetic analysis using quantitative, high sensitivity, fluorescence hybridization. Proc Natl Acad Sci USA 1986;83:2934-8.
38. Ried T, Baldini A, Rand TC, Ward DC. Simultaneous visualization of seven different DNA probes using combinatorial fluorescence and digital imaging microscopy. Proc Natl Acad Sci USA 1992;89: 1388-92.
39. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989.
40. Schröck E, du Manoir S, Veldman T, et al. Multicolor spectral karyotyping of human chromosomes. Science 1996;273:494-7.
41. Suciu S, Kuse R, Weh HJ, et al. Results of chromosome studies and their relation to morphology, course, and prognosis in 120 patients with de nove myelodysplastic syndrome. Cancer Genet Cytogenet 1990;44:15-26.
42. United Kingdom Cancer Cytogenetics Group (UKCCG). Loss of the Y chromosome from normal and neoplastic bone marrows. Genes Chromosom Cancer 1992;5:83-8.
43. Torlakovic E, Litz CE, McClure JS, Brunning RD. Direct detection of the Philadelphia chromosome in CD 20 positive lymphocytes in chronic myeloid leukemia by tri-color immunophenotyping/FISH. Leukemia 1994;8:1940-3.
44. Ward BE, Gersen SL, Carelli MP, McGuire NM. Dackowski WR, Weinstein M, Sandlin C, Warren R, Klinger KW. Rapid prenatal diagnosis of chromosomal aneuploidies by fluorescence in situ hybridization: clinical experience with 4,500 specimens. Am J Hum Genet 1993;52:854-65.
45. Werner M, Maschek H, Kaloutsi V, et al. Chromosome analyses in patients with myelodysplastic syndromes: Correlation with bone marrow histopathology and prognostic significance. Virchows Arch A Pathol Anat 1992;421:47-52.
46. Werner M, Nolte M, Kaloutsi M, Buhr T, Kausche F, Georgii A. Karyotype findings and molecular analysis of the bcr gene rearrangement supplementing the histological classification of chronic myeloproliferative disorders. Lab Invest 1995;72:405-10.
47. Yunis JJ, Lobell M, Arnesen MA, et al. Refined chromosome study helps define prognostic subgroups in most patients with primary myelodysplastic syndrome and acute myelogeneous leukemia. Br J Haematol 1988;68:189-94.